Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transglutaminase 2 (TG2) inhibitors

Transglutaminase 2 (TG2) inhibitors

US Patent 11548892 · Granted Jan 10, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods related to tumor activated antibodies targeting EGFR an2025
Compositions and methods related to tumor activated antibodies targeting EGFR an2024
Transglutaminase 2 (TG2) inhibitors2024
Transglutaminase 2 (TG2) inhibitors2024
Transglutaminase 2 (TG2) inhibitors2024
Transglutaminase 2 (TG2) inhibitors2024
Anti-MICA/B antibodies that block MICA/B shedding and methods of use2024
Auris formulations for treating otic diseases and conditions2024
Compositions and methods related to tumor activated antibodies targeting PSMA an2023
Cleavable linker compositions and methods2022
Controlled-release CNS modulating compositions and methods for the treatment of 2021
ASK1 isoindolin-1-one inhibitors and methods of use thereof2020